These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27163517)

  • 1. Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo.
    Eigeliene N; Kangas L; Hellmer C; Kauko T; Erkkola R; Härkönen P
    Menopause; 2016 Jul; 23(7):719-30. PubMed ID: 27163517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and the selective estrogen receptor modulator (SERM) protection against cell death in estrogen receptor alpha and beta expressing U2OS cells.
    Kallio A; Guo T; Lamminen E; Seppänen J; Kangas L; Väänänen HK; Härkönen P
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):38-48. PubMed ID: 18455292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the Effects of the Selective Estrogen Receptor Modulators Ospemifene, Raloxifene, and Tamoxifen on Breast Tissue in Ex Vivo Culture.
    Eigeliene N; Erkkola R; Härkönen P
    Methods Mol Biol; 2016; 1366():327-336. PubMed ID: 26585146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus.
    Stygar D; Muravitskaya N; Eriksson B; Eriksson H; Sahlin L
    Reprod Biol Endocrinol; 2003 May; 1():40. PubMed ID: 12777179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the short-term effects of a novel selective estrogen receptor modulator, ospemifene, and raloxifene and tamoxifen on rat uterus.
    Zheng H; Kangas L; Härkönen PL
    J Steroid Biochem Mol Biol; 2004 Feb; 88(2):143-56. PubMed ID: 15084346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements.
    Ball LJ; Levy N; Zhao X; Griffin C; Tagliaferri M; Cohen I; Ricke WA; Speed TP; Firestone GL; Leitman DC
    Mol Cell Endocrinol; 2009 Feb; 299(2):204-11. PubMed ID: 19059307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships of the raloxifene-estrogen receptor-alpha complex for regulating transforming growth factor-alpha expression in breast cancer cells.
    Liu H; Park WC; Bentrem DJ; McKian KP; Reyes Ade L; Loweth JA; Schafer JM; Zapf JW; Jordan VC
    J Biol Chem; 2002 Mar; 277(11):9189-98. PubMed ID: 11751902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the environmental estrogens bisphenol A, o,p'-DDT, p-tert-octylphenol and coumestrol on apoptosis induction, cell proliferation and the expression of estrogen sensitive molecular parameters in the human breast cancer cell line MCF-7.
    Diel P; Olff S; Schmidt S; Michna H
    J Steroid Biochem Mol Biol; 2002 Jan; 80(1):61-70. PubMed ID: 11867264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues.
    Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS
    J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance to selective estrogen receptor modulators (SERMs) in clinical practice (tamoxifen & raloxifene) by selection pressure in breast cancer cell populations.
    Fan P; Craig Jordan V
    Steroids; 2014 Nov; 90():44-52. PubMed ID: 24930824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic action of 17beta-estradiol in raloxifene-resistant MCF-7 cells in vitro and in vivo.
    Liu H; Lee ES; Gajdos C; Pearce ST; Chen B; Osipo C; Loweth J; McKian K; De Los Reyes A; Wing L; Jordan VC
    J Natl Cancer Inst; 2003 Nov; 95(21):1586-97. PubMed ID: 14600091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective estrogen receptor modulators regulate stromal proliferation in human benign prostatic hyperplasia by multiple beneficial mechanisms--action of two new agents.
    Kumar R; Verma V; Sarswat A; Maikhuri JP; Jain A; Jain RK; Sharma VL; Dalela D; Gupta G
    Invest New Drugs; 2012 Apr; 30(2):582-93. PubMed ID: 21181231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of selective oestrogen receptor modulators (SERMs) tamoxifen, ospemifene and raloxifene on human osteoclasts in vitro.
    Michael H; Härkönen PL; Kangas L; Väänänen HK; Hentunen TA
    Br J Pharmacol; 2007 Jun; 151(3):384-95. PubMed ID: 17420779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raloxifene induces cell death and inhibits proliferation through multiple signaling pathways in prostate cancer cells expressing different levels of estrogen receptor α and β.
    Rossi V; Bellastella G; De Rosa C; Abbondanza C; Visconti D; Maione L; Chieffi P; Della Ragione F; Prezioso D; De Bellis A; Bellastella A; Sinisi AA
    J Cell Physiol; 2011 May; 226(5):1334-9. PubMed ID: 20945400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta.
    Tee MK; Rogatsky I; Tzagarakis-Foster C; Cvoro A; An J; Christy RJ; Yamamoto KR; Leitman DC
    Mol Biol Cell; 2004 Mar; 15(3):1262-72. PubMed ID: 14699072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERα-independent NRF2-mediated immunoregulatory activity of tamoxifen.
    Pepe G; Sfogliarini C; Rizzello L; Battaglia G; Pinna C; Rovati G; Ciana P; Brunialti E; Mornata F; Maggi A; Locati M; Vegeto E
    Biomed Pharmacother; 2021 Dec; 144():112274. PubMed ID: 34653752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgens inhibit the stimulatory action of 17β-estradiol on normal human breast tissue in explant cultures.
    Eigeliene N; Elo T; Linhala M; Hurme S; Erkkola R; Härkönen P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):E1116-27. PubMed ID: 22535971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake.
    Todorova VK; Kaufmann Y; Luo S; Klimberg VS
    Cancer Chemother Pharmacol; 2011 Feb; 67(2):285-91. PubMed ID: 20383709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.